Application 020744

Type
BLA
Sponsor
CHIESI USA INC

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
020744Curosurfporactant alfa351(a)Rx2026-08-01

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CUROSURFPORACTANT ALFASUSPENSION;INTRATRACHEAL80MG/MLNoNo

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CurosurfPORACTANT ALFAChiesi USA, Inc.99bef307-00bd-4379-9f45-ede1380e74d42025-12-10Warnings, Adverse reactionsExact identifier
application number: BLA020744
ndc (product): 10122-510

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 6 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
10122-510Curosurfporactant alfaChiesi USA, Inc.BLACurrent
10122-510Curosurfporactant alfaChiesi USA, Inc.NDACurrent
10122-510Curosurfporactant alfaChiesi USA, Inc.NDACurrent
10122-510Curosurfporactant alfaChiesi USA, Inc.BLACurrent
10122-510Curosurfporactant alfaChiesi USA, Inc.NDACurrent
10122-510Curosurfporactant alfaChiesi USA, Inc.BLACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
67547SUPPL2021-05-19
67542SUPPL2021-05-18
66398APPL2020-03-23
61333SUPPL2020-03-23
61323SUPPL2020-03-23
35260SUPPL2020-03-23
35259SUPPL2020-03-23
35258ORIG2020-03-23
25678SUPPL2020-03-23
25677SUPPL2020-03-23
25676SUPPL2020-03-23
25675SUPPL2020-03-23
20894ORIG2020-03-23
3249ORIG2020-03-23